College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, Jiangsu, China;School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China 在期刊界中查找 在百度中查找 在本站中查找
[Objective] To investigate the antibacterial effect of the phage endolysin Lysin1902 combined with ε-poly-lysine (ε-PL) on Escherichia coli O157:H7. [Methods] We employed Mega to construct the phylogenetic tree and used online tools to analyze the amino acid sequence of Lysin1902. After prokaryotic expression, Lysin1902 was purified. We then detected the lytic activity of Lysin1902 against autoclaved E. coli O157:H7 by plate lysis assay and detected the lysis activity of Lysin1902 or ε-PL on live E. coli O157:H7 in 96-well plates. Further, we adopted checkerboard assay to measure the bactericidal activity of Lysin1902 combined with ε-PL. [Results] We successfully expressed and purified Lysin1902. Lysin1902 showed lytic activity against autoclaved E. coli O157:H7 but cannot effectively lyse live E. coli strains. After the addition of Lysin1902, the concentration of ε-PL that could completely control the proliferation of E. coli O157:H7 decreased from 0.7 mg/mL to 0.1 mg/mL. [Conclusion] Lysin1902 was successfully expressed and purified. Lysin1902 alone has no lytic activity against E. coli O157:H7, while the combined use of Lysin1902 with ε-PL significantly increased the lytic activity of ε-PL against E. coli O157:H7.
[1] PULIGUNDLA P, LIM S. Biocontrol approaches against Escherichia coli O157:H7 in foods[J]. Foods:Basel, Switzerland, 2022, 11(5):756.
[2] LI YK, CHEN H, SHU M, ZHONG C, BI Y, YANG HH, WU GP. Isolation, characterization and application of an alkaline resistant virulent bacteriophage JN01 against Escherichia coli O157:H7 in milk and beef[J]. LWT, 2021, 144:111266.
[3] O'FLYNN G, ROSS RP, FITZGERALD GF, COFFEY A. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7[J]. Applied and Environmental Microbiology, 2004, 70(6):3417-3424.
[4] VIDOVIC S, TSOI S, MEDIHALA P, LIU J, WYLIE JL, LEVETT PN, KORBER DR. Molecular and antimicrobial susceptibility analyses distinguish clinical from bovine Escherichia coli O157 strains[J]. Journal of Clinical Microbiology, 2013, 51(7):2082-2088.
[5] YANG X, WU YN, LIU Q, SUN H, LUO M, XIONG YW, MATUSSEK A, HU B, BAI XN. Genomic characteristics of Stx2e-producing Escherichia coli strains derived from humans, animals, and meats[J]. Pathogens:Basel, Switzerland, 2021, 10(12):1551.
[6] UM MM, BARRAUD O, KEROUREDAN M, GASCHET M, STALDER T, OSWALD E, DAGOT C, PLOY MC, BRUGERE H, BIBBAL D. Comparison of the incidence of pathogenic and antibiotic-resistant Escherichia coli strains in adult cattle and veal calf slaughterhouse effluents highlighted different risks for public health[J]. Water Research, 2016, 88:30-38.
[7] MODY RK, GRIFFIN PM. Editorial commentary:Increasing evidence that certain antibiotics should be avoided for shiga toxin-producing Escherichia coli infections:More data needed[J]. Clinical Infectious Diseases, 2016, 62(10):1259-1261.
[8] COLAVECCHIO A, GOODRIDGE LD. Phage therapy approaches to reducing pathogen persistence and transmission in animal production environments:opportunities and challenges[J]. Microbiology Spectrum, 2017, 5(3). doi:10.1128/microbiolspec. PFS-10.1128/microbiolspec0017-2017.
[9] GONDIL VS, HARJAI K, CHHIBBERhhibber S. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections[J]. International Journal of Antimicrobial Agents, 2020, 55(2):105844.
[10] WANG WY, LI MZ, LIN H, WANG JX, MAO XZ. The Vibrio parahaemolyticus-infecting bacteriophage qdvp001:Genome sequence and endolysin with a modular structure[J]. Archives of Virology, 2016, 161(10):2645-2652.
[11] 解天慧, 石慧. 大肠杆菌O157:H7噬菌体EC-p9的内溶酶和穿孔素的特性预测及克隆表达[J]. 食品与发酵工业, 2021(9):107-113. XIE TH, SHI H. Characteristics prediction and expression of endolysin and holin from E. coli O157:H7 phage EC-p9[J]. Food and Fermentation Industries, 2021(9):107-113(in Chinese).
[12] BRIERS Y, WALMAGH M, van PUYENBROECK V, CORNELISSEN A, CENENS W, AERTSEN A, OLIVEIRA H, AZEREDO J, VERWEEN G, PIRNAY JP, MILLER S, VOLCKAERT G, LAVIGNE R.. Engineered endolysin-based "artilysins" to combat multidrug-resistant gram-negative pathogens[J]. mBio, 2014, 5(4):e01379-e01314.
[13] HESELPOTH RD, EULER CW, SCHUCH R, FISCHETTI VA. Lysocins:bioengineered antimicrobials that deliver lysins across the outer membrane of gram-negative bacteria[J]. Antimicrobial Agents and Chemotherapy, 2019, 63(6):e00342-e00319.
[14] YAN GM, LIU JF, MA Q, ZHU RN, GUO ZM, GAO CC, WANG S, YU L, GU JM, HU DL, HAN WY, DU R, YANG JL, LEI LC. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly[J]. Antonie Van Leeuwenhoek, 2017, 110(12):1627-1635.
[15] YE RS, XU HY, WAN CX, PENG SS, WANG LJ, XU H, AGUILAR ZP, XIONG YH, ZENG ZL, WEI H. Antibacterial activity and mechanism of action of ε-poly-l-lysine[J]. Biochemical and Biophysical Research Communications, 2013, 439(1):148-153.
[16] WANG DH, WANG HM, WU JP, HOU YX, SUN JR, YUAN JF, GU SB. Biotechnological production and application of epsilon-poly-l-lysine (ε-PL):Biosynthesis and its metabolic regulation[J]. World Journal of Microbiology & Biotechnology, 2022, 38(7):123.
[17] JIAO WX, LIU X, CHEN QM, DU YM, LI YY, YUE FL, DONG XQ, FU MR. Epsilon-poly-l-lysine (ε-PL) exhibits antifungal activity in vivo and in vitro against Botrytis cinerea and mechanism involved[J]. Postharvest Biology and Technology, 2020, 168:111270.
[18] WANG YX, SUBEDI D, LI J, WU JL, REN JL, XUE F, DAI JJ, BARR JJ, TANG F. Phage cocktail targeting STEC O157:H7 has comparable efficacy and superior recovery compared with enrofloxacin in an enteric murine model[J]. Microbiology Spectrum, 2022, 10(3):e0023222.
[19] NING HQ, LIN H, WANG JX. Synergistic effects of endolysin Lysqdvp001 and ε-poly-lysine in controlling Vibrio parahaemolyticus and its biofilms[J]. International Journal of Food Microbiology, 2021, 343:109112.
[20] MICHAEL L, DAVID C, SALIM I, CRAIG B, CI DR. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84:Defining a new endolysin catalytic subfamily[J]. The Biochemical Journal, 2021, 479(2):207-223.
[21] LOVE MICHAEL J, DAVID C, MANNERS SARAH H, ABEYSEKERA GAYAN S, CRAIG B, DOBSON RENWICK CJ. The molecular basis for Escherichia coli O157:H7 phage FAHEc1 endolysin function and protein engineering to increase thermal stability[J]. Viruses, 2021, 13(6):1101.
[22] PARK DW, PARK JH. Characterization of endolysin LysECP26 derived from rV5-like phage vB_EcoM-ECP26 for inactivation of Escherichia coli O157:H7[J]. Journal of Microbiology and Biotechnology, 2020, 30(10):1552-1558.
[23] PROKHOROV DA, MIKOULINSKAIA GV, MOLOCHKOV NV, UVERSKY VN, KUTYSHENKO VP. High-resolution NMR structure of a Zn2+-containing form of the bacteriophage T5 l-alanyl-d-glutamate peptidase[J]. RSC Advances, 2015, 5(51):41041-41049.
[24] 杨曦, 吉文汇, 曹冬梅, 孙建和, 严亚贤. 大肠杆菌O157 Stx噬菌体裂解酶的克隆表达及活性分析[J]. 上海交通大学学报:农业科学版, 2012(4):25-30. YANG X, JI WH, CAO DM, SUN JH, YAN YX. Expression and antibacterial activity of stx phage endolysin of Escherichia coli O157[J]. Journal of Shanghai Jiao Tong University:Agricultural Science, 2012(4):25-30(in Chinese).